Cite
HARVARD Citation
Ang, Y. et al. (n.d.). 490POutcomes of sequential epidermal growth factor receptor tyrosine (EGFR) tyrosine kinase inhibitor (TKI) therapy in patients with advanced non-small cell lung carcinoma (NSCLC)- a real-world institutional experience. Annals of oncology. p. . [Online].